Uni-Pex Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 26 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.75 Cr
- Satisfied Charges ₹ 20.00 Cr
- Revenue Growth 98.35%
- Profit Growth 17.88%
- Ebitda -150.89%
- Net Worth 7.42%
- Total Assets 57.15%
About Uni-Pex Pharmaceuticals
Uni-Pex Pharmaceuticals Private Limited (UPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 March 1999 and has a history of 26 years and one month. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹1.75 Cr. The company has closed loans amounting to ₹20.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Madan Bansal and Jagdish Bansal serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231DL1999PTC098759
- Company No.
098759
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Mar 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Uni-Pex Pharmaceuticals Private Limited
Explore comprehensive data for Uni-Pex Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Uni-Pex Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madan Bansal  | Director | 10-Mar-1999 | Current |
| Jagdish Bansal | Director | 10-Mar-1999 | Current |
Financial Performance of Uni-Pex Pharmaceuticals.
Uni-Pex Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 98.35% increase. The company also saw a substantial improvement in profitability, with a 17.88% increase in profit. The company's net worth moved up by a moderate rise of 7.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Uni-Pex Pharmaceuticals?
In 2023, Uni-Pex Pharmaceuticals had a promoter holding of 72.33% and a public holding of 27.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Maxtar Bio-Genics Private LimitedMadan Bansal and Jagdish Bansal are mutual person
Crysta Healthcare Private LimitedMadan Bansal is a mutual person
- Unipex Bio Science Private Limited
Jagdish Bansal is a mutual person
Charges (Loans)
Open Charges
₹17.50 M
Satisfied Charges
₹200.00 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 1.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Nov 2021 | Hdfc Bank Limited | ₹1.75 Cr | Open |
| 14 Sep 2022 | Hdfc Bank Limited | ₹20.00 Cr | Satisfied |
How Many Employees Work at Uni-Pex Pharmaceuticals?
Unlock and access historical data on people associated with Uni-Pex Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Uni-Pex Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uni-Pex Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Uni-Pex Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Uni-Pex Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Charges
A charge registered on 14 Sep 2022 via Charge ID 100621504 with Hdfc Bank Limited was fully satisfied on 02 Sep 2024.
- Balance Sheet
Uni-Pex Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Charges
A charge with Hdfc Bank Limited amounted to Rs. 200.00 M with Charge ID 100621504 was registered on 14 Sep 2022.
- Charges
A charge with Hdfc Bank Limited amounted to Rs. 17.50 M with Charge ID 100531614 was registered on 23 Nov 2021.
- Director Appointment
Madan Lal Bansal was appointed as a Director was appointed as a Director on 10 Mar 1999 & has been associated with this company since 26 years 1 month .
Frequently asked questions
What is the Incorporation or founding date of Uni-Pex Pharmaceuticals Private Limited?
Uni-Pex Pharmaceuticals Private Limited was incorporated on 10 Mar 1999.
What is authorized share capital and paid-up capital of Uni-Pex Pharmaceuticals Private Limited?
The authorized share capital of Uni-Pex Pharmaceuticals Private Limited is ₹ 5.00 M and paid-up capital is ₹ 5.00 M.
Who are the current board members & directors of Uni-Pex Pharmaceuticals Private Limited?
Currently 2 directors are associated with Uni-Pex Pharmaceuticals Private Limited.
- Madan Lal Bansal
- Jagdish Chand Bansal
What is the registered address of Uni-Pex Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Uni-Pex Pharmaceuticals Private Limited is 801 8Th Floor Gopal Heights Netaji Subhash Place, Pitampura India, Delhi, 110034.
What is the corporate identification number (CIN) and company number of Uni-Pex Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Uni-Pex Pharmaceuticals Private Limited is U24231DL1999PTC098759 and the company number is 098759 as per Ministry of Corporate Affairs (MCA).
What is the official website of Uni-Pex Pharmaceuticals Private Limited?
The Official website of Uni-Pex Pharmaceuticals Private Limited is https://www.unipexpharmaceuticals.com
What has been the recent revenue trend for Uni-Pex Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Uni-Pex Pharmaceuticals Private Limited has risen by 98.35%.
What change has been observed in the net worth of Uni-Pex Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Uni-Pex Pharmaceuticals Private Limited has experienced an upsurge of 7.42%.
What are the total open charges for Uni-Pex Pharmaceuticals Private Limited?
As per the financial statements for fiscal Year 2022, The total open charges for Uni-Pex Pharmaceuticals Private Limited amount to ₹ 1.75 Cr.
When was the last Balance Sheet of Uni-Pex Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Uni-Pex Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
Rajesh BansalDirector
Similar Companies Based on Drug Formulation & Development
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Vadodara, Gujarat, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India